Latest filing published 13 Oct 2026 for Castle Biosciences INC, €384k. Read the official filing
Tobin Juvenal appears in our data through filings on Castle Biosciences Inc shares, published by SEC (Form 4). Over a trading history stretching from 31 July 2026 to 12 October 2026, the count stands at 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 13 October 2026 came the latest disclosure, a transaction for €384k in Castle Biosciences Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations